Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04964063 · ClinicalTrials.gov registry record · NA
A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 655
- Enrollment target
NCT04964063: Completed NA study, sponsored by HALEON.
NCT04964063 is a NA study that has completed, run by HALEON. The registered enrollment target is 655 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04964063, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 655 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in oral health-related quality of life (OHrQoL) in participants suffering from Dentinal Hypersensitivity (DH) symptoms following the use of anti-sensitivity toothpaste for 24 weeks.
Primary Outcome
All the participants scored question No. 1 to 3 (\[Q1: On a scale of 1 to 10 how intense were the sensations?\] of section 1 of DHEQ on a scale of 1 to 10, where 1 is equal to (=) not at all intense and 10= worst imaginable, \[Q2: On a scale of 1 to 10 how bothered were you by any sensations?\] of section 1 of DHEQ on a scale of 1 to 10, where 1= Not at all bothered and 10= Extremely bothered\], \[Q3: On a scale of 1 to 10 how well could you tolerate sensations?\] of section 1 of DHEQ on a scale
Interventions
- OTHER Potassium Nitrate + Sodium Fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 655 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2022-05-13 |
| Phase | NA |
What the finished NCT04964063 record still lists
NCT04964063 is an interventional study that assigns participants to a tested intervention. The registered 655 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Potassium Nitrate + Sodium Fluoride is the first listed.
NCT04964063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04964063 about?
NCT04964063 is a clinical study titled "A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste". The purpose of this study is to evaluate changes in oral health-related quality of life (OHrQoL) in participants suffering from Dentinal Hypersensitivity (DH) symptoms following the use of anti-sensitivity toothpaste for 24 weeks.
What is the current status of trial NCT04964063?
This trial is currently completed. It is a NA study. The enrollment target is 655 participants. The study started on 2021-08-31. Estimated completion is 2022-05-13.
What interventions are being tested in trial NCT04964063?
The interventions under investigation include: Potassium Nitrate + Sodium Fluoride (OTHER).
Who is sponsoring clinical trial NCT04964063?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04964063's enrollment target sits among peer trials
655 156th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07145515 · 655 participants · NA
Enhancing Heart Allograft Function With the OCS Heart System Trial
- NCT05407129 · 656 participants · NA
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
- NCT06127199 · 656 participants · NA
Contraceptive Efficacy Study of Ovaprene
- NCT03671044 · 657 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI